P570: VENETOCLAX PLUS HYPOMETHYLATING AGENTS VERSUS INTENSIVE CHEMOTHERAPY FOR HEMATOLOGICAL RELAPSE OF MYELOID MALIGNANCIES AFTER ALLO-HSCT

por Chen, Zhangjie, Zhen, Sisi, Chen, Xin, Feng, Sizhou
Publicado 2023

P1527: ASSESSMENT OF RISK FACTORS AND ANTIMICROBIAL THERAPY FOR CARBAPENEM-RESISTANT PSEUDOMONAS AERUGINOSA BLOODSTREAM INFECTIONS IN HEMATOLOGICAL PATIENTS

por Chen, Zhangjie, Zhen, Sisi, Zhao, Yuanqi, Feng, Sizhou
Publicado 2023

Characterization of Hypoxia Signature to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Glioma Groups

por Lin, Wanzun, Wu, Shihong, Chen, Xiaochuan, Ye, Yuling, Weng, Youliang, Pan, Yuhui, Chen, Zhangjie, Chen, Long, Qiu, Xianxin, Qiu, Sufang
Publicado 2020

A three-lncRNA signature predicts clinical outcomes in low-grade glioma patients after radiotherapy

por Lin, Wanzun, Huang, Zongwei, Xu, Yanyan, Chen, Xiaochuan, Chen, Ting, Ye, Yuling, Ding, Jianming, Chen, Zhangjie, Chen, Long, Qiu, Xianxin, Qiu, Sufang
Publicado 2020

Assessment of mortality-related risk factors and effective antimicrobial regimens for treatment of bloodstream infections caused by carbapenem-resistant Pseudomonas aeruginosa in p...

por Zhen, Sisi, Zhao, Yuanqi, Chen, Zhangjie, Zhang, Tingting, Wang, Jieru, Jiang, Erlie, Zhang, Fengkui, Mi, Yingchang, Zhu, Xiaofan, Han, Mingzhe, Xiao, Zhijian, Wang, Jianxiang, Feng, Sizhou
Publicado 2023

Venetoclax plus hypomethylating agents versus intensive chemotherapy for hematological relapse of myeloid malignancies after allo-HSCT

por Chen, Zhangjie, Zhen, Sisi, Zhang, Tingting, Shen, Yuyan, Pang, Aiming, Yang, Donglin, Zhang, Rongli, Ma, Qiaoling, He, Yi, Wei, Jialin, Zhai, Weihua, Chen, Xin, Jiang, Erlie, Han, Mingzhe, Feng, Sizhou
Publicado 2023